SCHEMBL6888812

SCHEMBL6888812

Cc1cc(CC=O)c(OCc2ccccc2)c([N+](=O)[O-])c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.42
▸ ADRA1D P25100 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ ADRA1B P35368 1/20 0.42
▸ PIN1 Q13526 2/20 0.41
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ CYP19A1 P11511 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ ATM Q13315 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ TLR4 O00206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10357060 0.81 PTGER4 (0.43) MAPTMEN1KMT2AATMLMNA
SCHEMBL11067298 0.80 HTR1A (0.54) HTR1AADRA1DADRA1AADRA1BMAPT
SCHEMBL6458856 0.78 MEN1 (0.48) MAPTMEN1KMT2ACYP19A1CYP2C9
SCHEMBL6882078 0.77 HPD (0.39) PIN1MAPTMEN1KMT2ACYP19A1
SCHEMBL3952879 0.76 ALDH1A1 (0.57) HTR1AADRA1DADRA1AADRA1BMAPT
SCHEMBL11451207 0.75 MAPT (0.50) HTR1AADRA1DADRA1AADRA1BPIN1
SCHEMBL16378450 0.75 MAPT (0.39) HTR1AADRA1DADRA1AADRA1BPIN1
SCHEMBL17746516 0.75 MAPT (0.39) HTR1AADRA1DADRA1AADRA1BPIN1
SCHEMBL5024079 0.74 BACE1 (0.46) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL4290434 0.74 POLB (0.55) HTR1AADRA1DADRA1AADRA1BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004110351-A2 HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS ANADYS PHARMACEUTICALS, INC. (US) 2004-12-23 — — WO disclosed
Send feedback